Carregant...
The interaction of ifosfamide and aprepitant in gynecologic malignancies()
• Aprepitant combined with ifosfamide may lead to encephalopathy. • Aprepitant–ifosfamide induced encephalopathy was of short duration in these cases.
Guardat en:
| Autors principals: | , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Elsevier
2013
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3862235/ https://ncbi.nlm.nih.gov/pubmed/24371715 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.gynor.2013.06.002 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|